EphB receptor activity suppresses colorectal cancer progression.

E. Batlle, J. Bacani, H. Begthel, S. Jonkheer, A. Gregorieff, M.van de Born, N. Malats, E. Sancho, E. Boon, T. Pawson, S. Gallinger, S. Pals, J.C. Clevers

Research output: Contribution to journal/periodicalArticleScientificpeer-review

353 Citations (Scopus)


Most sporadic colorectal cancers are initiated by activating Wnt pathway mutations, characterized by the stabilization of beta-catenin and constitutive transcription by the beta-catenin/T cell factor-4 (Tcf-4) complex. EphB guidance receptors are Tcf4 target genes that control intestinal epithelial architecture through repulsive interactions with Ephrin-B ligands. Here we show that, although Wnt signalling remains constitutively active, most human colorectal cancers lose expression of EphB at the adenoma-carcinoma transition. Loss of EphB expression strongly correlates with degree of malignancy. Furthermore, reduction of EphB activity accelerates tumorigenesis in the colon and rectum of Apc(Min/+) mice, and results in the formation of aggressive adenocarcinomas. Our data demonstrate that loss of EphB expression represents a critical step in colorectal cancer progression.
Original languageEnglish
Pages (from-to)1126-1130
Publication statusPublished - 2005


Dive into the research topics of 'EphB receptor activity suppresses colorectal cancer progression.'. Together they form a unique fingerprint.

Cite this